Integer Holdings (Integer Holdings) Days Sales Outstanding

: 51.31 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

Integer Holdings's average Accounts Receivable for the three months ended in Dec. 2023 was $232 Mil. Integer Holdings's Revenue for the three months ended in Dec. 2023 was $413 Mil. Hence, Integer Holdings's Days Sales Outstanding for the three months ended in Dec. 2023 was 51.31.

The historical rank and industry rank for Integer Holdings's Days Sales Outstanding or its related term are showing as below:

ITGR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 50.59 Med: 58.17 Max: 75.77
Current: 53.77

During the past 13 years, Integer Holdings's highest Days Sales Outstanding was 75.77. The lowest was 50.59. And the median was 58.17.

ITGR's Days Sales Outstanding is ranked better than
63.29% of 809 companies
in the Medical Devices & Instruments industry
Industry Median: 63.91 vs ITGR: 53.77

Integer Holdings's Days Sales Outstanding declined from Dec. 2022 (53.94) to Dec. 2023 (51.31).

Integer Holdings Days Sales Outstanding Historical Data

The historical data trend for Integer Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integer Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

54.76

59.20

50.59

53.93

52.88

Integer Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding																53.94	57.19	55.55	52.18	51.31

Competitive Comparison

For the Medical Devices subindustry, Integer Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Integer Holdings Days Sales Outstanding Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Integer Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Integer Holdings's Days Sales Outstanding falls into.

Integer Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Integer Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (224.325	+	238.277)	/	2 )	/	1596.673	*	365
=	231.301					/	1596.673	*	365
=	52.88

Integer Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (226.327	+	238.277)	/	2 )	/	413.151	*	365 / 4
=	232.302					/	413.151	*	365 / 4
=	51.31

Integer Holdings (NYSE:ITGR) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Integer Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Integer Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Integer Holdings (Integer Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integer Holdings Corp (NYSE:ITGR) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

WGB:Germany

Address

5830 Granite Parkway, Suite 1150, Plano, TX, USA, 75024

Website

https://www.integer.net

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States.

Executives

Donald J Spence	director	C/O OAKMONT ACQUISITION CORP., 33 BLOOMFIELD HILLS PARKWAY, SUITE 240, BLOOMFIELD HILLS MI 48304
Jean M. Hobby	director	10000 WEHRLE DRIVE, CLARENCE NY 14031
Jim Stephens	officer: President, CRM & Neuro	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Diron Smith	officer: VP, Interim CFO	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Joseph W Dziedzic	director	1801 BAYBERRY COURT, RICHMOND VA 23226
Pamela G Bailey	director	1200 G ST NW, STE 400, WASHINGTON DC 20005-3814
Jennifer M Bolt	officer: President, Electrochem	10000 WEHRLE DRIVE, CLARENCE NY 14031
Carter Houghton	officer: President, Electrochem	10000 WEHRLE DRIVE, CLARENCE NY 14031
Andrew Senn	officer: SVP, Strategy and Business Dev	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Marshall Mcalister C Ii	officer: SVP, Gen Counsel & Secretary	1801 BAYBERRY COURT, P.O. BOX 18100, RICHMOND VA 23226
Margaret Carthy	officer: SVP, Quality & Regulatory Affa	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Joseph F Flanagan	officer: EVP, Quality & Regulatory Affa	10000 WEHRLE DRIVE, CLARENCE NY 14031
Bill R Sanford	director	2617 BULRUSH LANE, NAPLES FL 34105
Anthony W Borowicz	officer: SVP Strategy,Corp Dev., IR	10000 WEHRLE DRIVE, CLARENCE NY 14031
Sheila Antrum	director	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024